Detailed text transcripts for TV channel - CNN - 20161226:05:42:00
Whove tried an fda-approved targeted therapy, this is big. a chance to live longer with opdivo (nivolumab). opdivo demonstrated longer life and is the most prescribed immunotherapy for these patients. opdivo significantly increased the chance of living longer versus chemotherapy. opdivo works with your immune system. opdivo can cause your immune system to attack normal organs and tissues in your body and affect how they work. this may happen any time during or after treatment has ended, and may ...
Source: news source